Skip to main content
. 2012 Mar 29;7(3):e34545. doi: 10.1371/journal.pone.0034545

Figure 1. Plating efficiency and percentage of stem cells.

Figure 1

(A) Plate efficiency of breast cancer cell lines and patient-derived tumor samples in clonogenic survival assays under normoxic and hypoxic conditions. (B) Percentage of ZsGreen-cODC+ BCSCs in established breast cancer cell lines. (C) Percentage of ALDH+ cells in established breast cancer cell lines and patient-derived tumor samples.